Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDEX for chronic liver disease with metabolic syndrome
KCT0003908Phase 4Recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Udex in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Pharmbio Korea Inc.. Started Jan 2018; status: recruiting.
02
Drugs
Udex
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on KCT0003908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003908.